Jim Wilson, Chairman and CEO of ZEA Biosciences, has joined Shepherd Ventures III as a Strategic Partner, to assist in the fund’s strategic execution.
AUSTIN, TX, UNITED STATES, April 30, 2026 /EINPresswire.com/ — Shepherd Ventures III today announced that Jim Wilson, Chairman and CEO of ZEA Biosciences, has joined the firm as Strategic Partner, marking a significant step in the fund’s expansion of capital formation capabilities and strategic execution.
Wilson brings a proven track record of building investor networks, leading complex financings, and structuring high-impact transactions in life sciences and technology. His addition signals Shepherd Ventures III’s commitment to scaling both capital inflows and its innovative form of deal sourcing as it grows its platform.
“This is a pivotal addition for us,” said George Kenney, Co-Managing Partner of Shepherd Ventures III. “We’ve built a strong foundation around disciplined investing and leadership assessment. Jim adds a new dimension—he brings velocity to capital and the ability to turn strategy into execution quickly.”
Robert Kramarz, Co-Managing Partner, added: “What makes this addition to our team powerful is the complement of skill sets. George and I have built a rigorous framework for evaluating leadership and risk. Jim brings the capital formation engine and transaction capability to create a more scalable venture platform.”
In his role, Wilson will focus on:
· Driving capital formation across institutional and strategic investor networks
· Originating and structuring differentiated investment opportunities
· Supporting portfolio companies on growth, partnerships, and strategic positioning
· Enhancing Shepherd Ventures III’s institutional footprint as it scales
“This is about building momentum,” said Wilson. “Shepherd Ventures III has the foundation—what we’re doing now is accelerating capital, sharpening execution, and expanding the platform. I’m excited to help drive that next phase.”
The appointment comes as Shepherd Ventures III continues to expand its investment activity across MedTech, FinTech, and AI, targeting companies with strong leadership and scalable models.
Shepherd Ventures III is a Venture Capital Fund specializing in assessing founding teams with an organizational development perspective. Like its predecessor Fund II, it expects that almost all portfolio companies will require a major pivot before succeeding and exiting. To this end, Shepherd Ventures III focuses on the leadership team as a unit, more than their resumes and the business plan, to ensure the team remains together and handles pivots well.
Robert Kramarz
Intelliversity
robk@intelliversity.org
Visit us on social media:
LinkedIn
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
